GlucoNorm | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

GlucoNorm
EDQM

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

pharmacompass-2-m-2025-11-03

GlucoNorm

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 12 USDMF, 11 CEP/COS, 3 JDMF, 8 EU WC, 2 KDMF, 6 NDC API, 18 Listed Suppliers, $ API Reference Price

29 API Suppliers
12 USDMF
11 CEP/COS
3 JDMF
8 EU WC
2 KDMF
6 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

40 Drugs in Development

40 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

329 FDF Dossiers, 31 FDA Orange Book, 252 Europe, 15 Canada, 6 South Africa, 25 Listed Dossiers

329 FDF Dossiers
31 FDA Orange Book
252 Europe
15 Canada
6 South Africa
25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG;1MG, TABLET;ORAL - 500MG;2MG

TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG;1MG
TABLET;ORAL - 500MG;2MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 6 SPI Pharma, 3 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 5 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 27 BASF, 1 Corel Pharma Chem, 3 DFE Pharma, 1 Doshion Polyscience, 2 Esteem Industries, 2 Finar, 9 Gangwal Chemicals, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 1 Kerry, 2 Keval Exports, 8 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 25 Roquette, 1 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 22 Direct Compression, 20 Granulation, 20 Solubilizers, 20 Thickeners and Stabilizers, 20 Disintegrants & Superdisintegrants, 17 Topical, 16 Lubricants & Glidants, 16 Film Formers & Plasticizers, 15 Taste Masking, 13 Coating Systems & Additives, 13 Co-Processed Excipients, 12 Controlled & Modified Release, 11 Parenteral, 9 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 2 API Stability Enhancers, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 2 Rheology Modifiers, 1 Soft Gelatin

47 Fillers, Diluents & Binders
22 Direct Compression
20 Granulation
20 Solubilizers
20 Thickeners and Stabilizers
20 Disintegrants & Superdisintegrants
17 Topical
16 Lubricants & Glidants
16 Film Formers & Plasticizers
15 Taste Masking
13 Coating Systems & Additives
13 Co-Processed Excipients
12 Controlled & Modified Release
11 Parenteral
9 Chewable & Orodispersible Aids
6 Emulsifying Agents
2 API Stability Enhancers
2 Surfactant & Foaming Agents
2 Coloring Agents
2 Rheology Modifiers
1 Soft Gelatin

DIGITAL CONTENT

8 News #PharmaBuzz

8 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 99 Regulatory FDF Prices, 5 Annual Reports

4 US Medicaid Prescriptions
99 Regulatory FDF Prices
5 Annual Reports

MARKET PLACE

7 APIs, 2 FDF Dossiers

7 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 6 Others

3 EDQM
6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,464 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

3 All

01 1Y0000457

02 1Y0000458

03 1Y0000459

filter CAS Number Reset all filters

3 All

01 2135062-02-1

02 1147770-08-9

filter Reference Standard Reset all filters

3 All

01 1Repaglinide

02 1Repaglinide for system suitability

03 1Repaglinide impurity E

Product Main Page

01

EDQM, Council of Europe

Repaglinide for system suitability

BIO Partnering at JPM

Not Confirmed

01

EDQM, Council of Europe

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Repaglinide for system suitability

CAS Number : 135062-02-1

Quantity Per Vial : 6 mg

Sale Unit : 1

Order Code : Y0000458

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Repaglinide impurity E

BIO Partnering at JPM

Not Confirmed

02

EDQM, Council of Europe

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Repaglinide impurity E

CAS Number : 147770-08-9

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0000459

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Repaglinide

BIO Partnering at JPM

Not Confirmed

03

EDQM, Council of Europe

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Repaglinide

CAS Number : 135062-02-1

Quantity Per Vial : 20 mg

Sale Unit : 1

Order Code : Y0000457

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.